Schedule 13G ownership disclosure

LORUS THERAPEUTICS INC

Security class unavailable · CUSIP: 544192305

Event date: 2014-04-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,000,000
Percent of class
11.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-14-000407
Form type
SC 13G
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Apr 14, 2014
Reporting period
Apr 03, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub